Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

7 Dec 2006 07:02

ReNeuron Group plc07 December 2006 Director Share Purchases Guildford, UK, 6 December 2006: ReNeuron Group plc (LSE: RENE) today announcesthe following purchases of ordinary shares in ReNeuron by directors of theCompany at 19.5p per share. Name Number of Shares Purchased Michael Hunt 51500John Sinden 36000Mark Docherty 51400(1)Trevor Jones 25700Paul Harper 57500 Following these purchases the directors of ReNeuron have the following interestsin issued ordinary shares in ReNeuron: Name Number of shares Percentage of issued share capitalMichael Hunt 174,613 0.18%John Sinden 1,219,925(2) 1.22%Mark Docherty 146,400(3) 0.15%Trevor Jones 83,200 0.08%Paul Harper 83,200 0.08% The current issued ordinary share capital of the Company is 99,604,700 shares. (1) = including 24,700 ordinary shares acquired by the MD FURBS, a funded unapproved retirement benefit scheme established by Mark Docherty (2) = in addition John Sinden holds 117,160 ordinary shares on trust for family members (3) = including 120,700 ordinary shares held by the MD FURBS, a funded unapproved retirement benefit scheme established by Mark Docherty ENDS Enquiries: ReNeuronMichael Hunt, CEO Tel: 44 (0)1483 302 560John Sinden, CSO Financial DynamicsDavid Yates Tel: 44 (0)20 7831 3113Nicola Daley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jun 20144:40 pmRNSSecond Price Monitoring Extn
24th Jun 20144:35 pmRNSPrice Monitoring Extension
20th Jun 20143:24 pmRNSNotification of Major Interest in Shares
20th Jun 20143:18 pmRNSNotification of Major Interest in Shares
18th Jun 20147:00 amRNSPreliminary Results
3rd Jun 20147:00 amRNSNotification of Preliminary Results
14th May 201412:00 pmRNSNotification of Major Interest in Shares
8th May 20149:00 amRNSNotification of Major Interest in Shares
7th May 20147:00 amRNSFurther Data from PISCES Trial
23rd Apr 20147:00 amRNSCorporate update
15th Apr 20147:00 amRNSSigns Lease to New Facility in Wales
27th Mar 20147:00 amRNSUK Clinical Trial Approvals
17th Mar 201411:00 amRNSBlock Listing Six Monthly Review
14th Mar 201412:45 pmRNSSupport for Early Access to Medicines Scheme
21st Jan 20147:00 amRNSPublication of Positive Pre-Clinical Data
27th Dec 20134:40 pmRNSSecond Price Monitoring Extn
27th Dec 20134:35 pmRNSPrice Monitoring Extension
10th Dec 20134:40 pmRNSSecond Price Monitoring Extn
10th Dec 20134:35 pmRNSPrice Monitoring Extension
2nd Dec 20137:00 amRNSInterim Results
19th Nov 20137:00 amRNSNotification of Interim Results
17th Sep 20137:00 amRNSDirectors' Interest in Shares and Share Options
13th Sep 201311:04 amRNSResults of 2013 Annual General Meeting
13th Sep 20137:00 amRNSAGM Trading Update
29th Aug 20137:00 amRNSOrphan Drug Designation
21st Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20137:00 amRNSDirector/PDMR Shareholding
15th Aug 20137:00 amRNSPosting of Annual Report & Notice of AGM
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
12th Aug 20137:00 amRNSDirector/PDMR Shareholding
7th Aug 201311:03 amRNSResult of General Meeting
1st Aug 20137:00 amRNSWins £1.5 Million Grant
22nd Jul 20137:01 amRNS£33 Million Financing Package
22nd Jul 20137:00 amRNSPreliminary Results
18th Jul 20134:40 pmRNSSecond Price Monitoring Extn
18th Jul 20134:35 pmRNSPrice Monitoring Extension
1st Jul 20137:00 amRNSNotification of Preliminary Results
1st Jul 20137:00 amRNSWelcomes House of Lords Report
5th Jun 20134:40 pmRNSSecond Price Monitoring Extn
5th Jun 20134:35 pmRNSPrice Monitoring Extension
28th May 20137:00 amRNSStroke Trial Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.